Navigation Links
Trophos Publishes ALS Article in Journal of Pharmacology and,Experimental Therapeutics

ophos. In vitro, TRO19622 promotes motor neuron survival in the absence of trophic support in a dose-dependent manner. In preclinical models in vivo, TRO19622 rescues motor neurons from axotomy-induced cell death in neonates and promotes nerve regeneration following sciatic nerve crush. Furthermore, in the SOD1G93A model of familial ALS, TRO19622 treatment improves motor performance, delays the onset of the clinical disease, and extends survival.

TRO19622 binds directly to two components of the mitochondrial permeability transition pore: the voltage-dependent anion channel (VDAC) and the translocator protein (or peripheral benzodiazepine receptor), suggesting a potential mechanism for its neuroprotective activity.

TRO19622 has successfully completed Phase I/Ib studies in both healthy volunteers and ALS patients demonstrating the product is well tolerated, has an excellent safety profile and that once-a-day dosing achieves the predicted exposure level required for efficacy, based on preclinical models. These data support the further clinical evaluation of TRO19622 as a potential treatment for ALS.

"Trophos is proud to have this body of work accepted for publication in a well recognized journal such as JPET," said Rebecca Pruss, CSO at Trophos. "Given the significant unmet medical need in ALS, it is tremendously encouraging that TRO19622 promotes the survival of motor neurons in this extensive battery of preclinical models. These studies, along with the excellent clinical safety profile of TRO19622, provide the basis upon which Trophos plans to initiate a pivotal Phase II/III trial to establish the clinical efficacy of TRO19622 in ALS patients."

Pruss added: "Moreover, we are particularly excited that there is increasing preclinical evidence that the mitochondria-mediated mechanism of action of TRO19622, and other compounds in this class, will have huge commercial potential in other chronic neurological disorders, such as neuropathic pain,
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Arrowhead Subsidiary, Insert, Publishes Interim Phase I Data from Human Clinical Trials for New Cancer Drug
2. New England Journal of Medicine Publishes New Data on Gardasil, Mercks Cervical Cancer Vaccine
3. The Lancet Publishes PREVAIL Study Results Showing Lovenox Superiority Over Unfractionated Heparin for Reducing the Risk of Venous ThromboEmbolism in Patients With Acute Ischemic Stroke
4. MedImmune Publishes New Data in Nature Immunology Demonstrating The Role HMGB1 May Play in Systemic Autoimmune Diseases
5. Arrowhead Subsidiary Calando Pharmaceuticals Publishes Study Showing Anti-Cancer Effect with Lead RNAi Candidate
6. Calando Pharmaceuticals Publishes Study Showing Anti-Cancer Effect with Lead RNAi Candidate
7. Medical Journal Publishes First Large-Scale Survey Revealing Experiences of IPF Patients
8. Arrowhead Subsidiary, Calando Pharmaceuticals Publishes Study on Targeted, Systemic Delivery of siRNA
9. Calando Pharmaceuticals Publishes the First Non-Human Primate Study on Targeted, Systemic Delivery of siRNA in National Academy of Sciences Journal
10. JACC Publishes Long-Term Safety and Tolerability Data from Ranolazine Open Label Experience (ROLE) Program
11. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
Post Your Comments:
(Date:5/28/2015)...  Eli Lilly and Company (NYSE: LLY ) announced ... for up to $1.6 billion aggregate principal amount (the "tender ... billion in aggregate principal amount of the notes listed in ... on or prior to 5:00 p.m., New York ... tender date for the offer. The table ...
(Date:5/27/2015)... , May 27, 2015 ... announced the addition of the  "2015 Strategies ...  report to their offering. ... pertaining to the UK NAT laboratory practice, ... social and technological trends with significant market ...
(Date:5/27/2015)... 2015 Research and ... of the  "North America Mammography Market - ...  report to their offering. ... a detailed type of imaging that customs ... A mammography exam, called a mammogram, is ...
Breaking Medicine Technology:Lilly Announces the Early Results of Its Cash Tender Offer 2Lilly Announces the Early Results of Its Cash Tender Offer 3Lilly Announces the Early Results of Its Cash Tender Offer 4Lilly Announces the Early Results of Its Cash Tender Offer 5North America Mammography Market - Growth, Trends And Forecasts (2014 - 2019) 2
(Date:5/28/2015)... (PRWEB) May 28, 2015 First ... freestanding emergency rooms in the United States, announced that ... new Denver – Green Valley Ranch facility. , ... increased access to the highest quality emergency medical care ... Valley Ranch facility,” said Dr. James M. Muzzarelli, Executive ...
(Date:5/28/2015)... SpendWell Health, an e-commerce marketplace for ... named a “Cool Vendor” by Gartner in the April ... Payers, 2015 by Jeff Cribbs, Constance Sjoquist, Robert ... vendors, products and services in health care technology—which serve ... care payer market. , SpendWell’s solution delivers the ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 Peggy J. Lynam, ... Delegate to the American Physical Therapy Association House of Delegates ... Delegation at their Delegate Assembly. This will be her ... Delegates serves as coordinator and principle spokesperson for the Chapter ... Board of Directors or Delegate Assembly may direct the Chief ...
(Date:5/27/2015)... Riverdale, NJ (PRWEB) May 28, 2015 Throughout ... a study site for research comparing the validity and reliability ... Dr. Preeti Nair, P.T., Ph.D., Associate Professor in the ... principle investigator for the study. , The Shaw Gait Assessment ... $30,000 piece of equipment. The GaitRite is considered the ...
(Date:5/27/2015)... StatRad, a leading provider of cloud-based medical ... Mr. Chris E. Hafey as its new Chief Technology ... of leading new development projects and has extensive experience ... served as the Chief Technology Officer for OnPoint Medical ... for Vital Images. , "I am very excited to ...
Breaking Medicine News(10 mins):Health News:First Choice Emergency Room to Open New Facility in Denver, Colorado 2Health News:SpendWell Named a “Cool Vendor” by Gartner 2Health News:SpendWell Named a “Cool Vendor” by Gartner 3Health News:SpendWell Named a “Cool Vendor” by Gartner 4Health News:Push to Walk Partners with Seton Hall University for Study 2Health News:StatRad Introduces Mr. Chris E. Hafey as Chief Technology Officer, and the Release of its Advanced Pure HTML5 DICOM Image Uploader 2
... ... who has been providing an invaluable service to consumers who are overwhelmed with ... a high rating by the BBB (Better Business Bureau).,New York, NY (PRWEB) ... and debt relief company, has become a proud member of the TASC (The ...
... Boston, Mass. About 40 percent of children and up ... leukemia (AML) will have a relapse. In recent years, doctors ... stem cells, endlessly replicating cancer cells that generate the immature ... cancer treatments. Now, researchers at Children,s Hospital Boston have found ...
... ... or capacity for change, in the neural circuitry of the visual cortex of juvenile mice. The ... human brain that would allow for the repair of neural circuits following injury or disease. ... San Francisco, CA (Vocus) March ...
... as lymph nodes, cancer can evade detection, researchers find ... from Switzerland provides insight into how tumors remain undetected ... , "The tumor tricks the body into thinking it ... the Laboratory of Lymphatic and Cancer Bioengineering, said in ...
... This press release is available in French ... have discovered a previously hidden channel to attack leukemia and ... the Journal of Biological Chemistry . The findings from ... change the way doctors treat cancer patients. "We found ...
... ... for cloud hosting technology, 2. What is web hosting, 3. What is cloud server web hosting, ... 6. Where you can get good cloud server web hosting , ... Burlington, VT (PRWEB) March 24, 2010 -- On March 25th 2010 Omega ...
Cached Medicine News:Health News:National Debt Relief Group Celebrates Proud Membership with TASC (The Association for Settlement Companies) 2Health News:Targeting cell pathway may prevent relapse of leukemia 2Health News:Targeting cell pathway may prevent relapse of leukemia 3Health News:New Period of Brain ‘Plasticity' Created with Transplanted Embryonic Cells 2Health News:New Period of Brain ‘Plasticity' Created with Transplanted Embryonic Cells 3Health News:New Period of Brain ‘Plasticity' Created with Transplanted Embryonic Cells 4Health News:New Period of Brain ‘Plasticity' Created with Transplanted Embryonic Cells 5Health News:New gateway to treat leukemia and other cancers 2Health News:Launching New Cloud Server Technologies on Website Hosting and Much Cheaper Web Hosting 2Health News:Launching New Cloud Server Technologies on Website Hosting and Much Cheaper Web Hosting 3Health News:Launching New Cloud Server Technologies on Website Hosting and Much Cheaper Web Hosting 4Health News:Launching New Cloud Server Technologies on Website Hosting and Much Cheaper Web Hosting 5Health News:Launching New Cloud Server Technologies on Website Hosting and Much Cheaper Web Hosting 6
Inquire...
Supercassette quick release holder for the 8000 Series sliding microtome to allow for the use of wax supercassettes, 75x52x19 mm....
... 5040 microtome is of rotary retracting, self-lubricating design ... cutting arm. Its robust construction makes it accurate ... hinges means that all lateral motion is controlled ... be experienced in other, lesser designs which can ...
Spare fuse set...
Medicine Products: